Auxly Cannabis Group Inc. (XLY) Earnings Call Transcripts

Auxly Cannabis Group Inc.'s Latest Earnings Call - Q4 FY2025

Auxly Cannabis Group Inc. reported strong financial results for Q4 and FY 2025, with significant improvements in revenue and profitability. The company achieved a net revenue of $151.5 million for the year, marking a 24% increase year-over-year, and an adjusted EBITDA of $43.8 million, up 64% YoY. Q4 net revenue reached $40.1 million, a 16% increase YoY. Management provided guidance for continued growth and profitability in 2026, supported by investments in distribution and innovation. The stock could be positively impacted by the company's profitability and strategic growth initiatives.

Reported metrics

Guidance from management

Management expects continued growth and profitability in 2026, with revenue growth above market rates and sustained profitability through efficiency investments and cost control.

What management said

Yes. Thanks, Neal. I mean, look, we don't want to say too much about the business that we're just a bidder at this point. But they are a significant player in our core categories and align well with our winning at home strategy and with our operating capabilities. So we think that if we are the winning bidder, this will be highly accretive to our shareholders, but we'll find out in a few days and have more to say at ...

Yes. I think that's right, Neal. This is Travis. I think we view our margin profile as sustainable off the back of 2025. I think gross margin starting with 5% internally is our benchmark, but we don't want to set any expectations beyond that. A lot of the improvements we've seen are structural in nature. For example, of course, Leamington cultivation and the automation, the procurement that Hugo discussed as well as ...

What analysts pressed on

Analysts expressed interest in the company's international expansion plans and the integration strategy for the potential Ayurcann acquisition. Concerns were also raised about sustaining gross margin improvements.

Main topics on the call

• Revenue Growth — Auxly reported a 24% increase in net revenue for FY 2025, reaching $151.5 million. Q4 revenue was $40.1 million, up 16% YoY. Management attributed growth to increased throughput and quality, higher volumes on vapes and p...
• Profitability — The company achieved an adjusted EBITDA of $43.8 million for FY 2025, representing a 64% increase YoY and an EBITDA margin of 29%. Q4 adjusted EBITDA was $12.5 million, up 14% YoY. Management highlighted improvements in ...
• Gross Margin Improvement — Gross margin on finished cannabis inventory sold increased to 54% for the year, up from 46% in 2024. Q4 gross margin was 56%. Management cited structural improvements in cultivation and automation as contributing factors...
• International Expansion Plans — Management discussed plans to build capabilities for international shipments, focusing initially on EU GMP standards. They emphasized a cautious approach, prioritizing domestic market success while testing international ...

Read the full Auxly Cannabis Group Inc. transcript (Q4 FY2025) → Summary generated from the call transcript; every figure above is stated by management on the record.

Earnings Call History

EarningsCalls.dev has 14 Auxly Cannabis Group Inc. earnings call transcripts on record, spanning July 15, 2020 to June 30, 2026. Based on this history, Auxly Cannabis Group Inc. reports semi-annually. The most recent call on file is dated June 30, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker

XLY

Exchange

TSX

Country

CA

Sector

Health Care

Industry

Pharmaceuticals

Calls on record

14

First call

July 15, 2020

Most recent

June 30, 2026

Reporting cadence

semi-annually